Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ERα antagonists(Estrogen receptor alpha antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H26F3NO2 |
InChIKeyDVZLOPUYTKPWHJ-MPWQXXDYSA-N |
CAS Registry2505067-70-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Discovery | CO | 17 Feb 2020 |